COVID-19 and ischemic stroke - How to tame a dozing monster

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.043E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2024
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr MV. prof Huisman MD PhD
  • Research Location

    Netherlands
  • Lead Research Institution

    Leids Universitair Medisch Centrum
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidity

  • Occupations of Interest

    Unspecified

Abstract

Patients with COVID-19 pneumonia, especially if they are admitted to intensive care, can develop thrombotic complications, which can contribute to a more serious course of COVID-19 pneumonia. Pulmonary embolism (clot in the lung) is the most common complication, but cerebral infarctions can also occur. The hypothesis in this study is that these strokes may be caused by clotting activation and vessel wall inflammation, or that they are the result of a blood clot that travels from the leg or pelvic vessels through an open connection between the right and left sides of the heart into the cerebral vessels. ends up. Research and expected outcomes In three work packages, knowledge is obtained about: an accurate estimate of the occurrence of cerebral infarctions in COVID-19 ICU patients. the causes and consequences of cerebral infarctions based on imaging studies and laboratory determinations. the optimal prevention of cerebral infarctions by examining the effect of different treatments.